Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Tomita

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Surgical Case Reports|April 13, 2026
Ileocecal CD5-Positive Diffuse Large B-Cell Lymphoma Presenting with Acute Obstructive Symptoms: A Case ReportJumpei Kashiwagi, Yutaka Hanaoka, Hana Yoshimitsu, et al.
The Laryngoscope|April 13, 2019
Three-dimensional assessment of the pharyngeal airway in Japanese preschoolers with orofacial cleftsMasahiro Takahashi, Tetsutaro Yamaguchi, Myoung K Lee, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
A Chemical Strategy toward Novel Brain-Penetrant EZH2 InhibitorsRui Liang, Daisuke Tomita, Yusuke Sasaki, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2019
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cellsEdouard Mullarky, Jiayi Xu, Anita D Robin, et al.
Journal of Human Genetics|June 7, 2018
Association between the FGFR1 rs13317 single nucleotide polymorphism and orbitale-nasion depth based on cephalometric imagesMohamed Adel, Tetsutaro Yamaguchi, Daisuke Tomita, et al.
Plos One|January 28, 2017
Contribution of FGFR1 Variants to Craniofacial Variations in East AsiansMohamed Adel, Tetsutaro Yamaguchi, Daisuke Tomita, et al.
Rheumatology (Oxford, England)|October 29, 2025
Clinical Efficacy of JAK Inhibitors for Rheumatoid Arthritis Patients with Poor-Prognosis Factors: The ANSWER Cohort StudyYuji Nozaki, Koichi Murata, Akira Onishi, et al.
Rheumatology (Oxford, England)|June 9, 2026
Comparative effectiveness and safety of sarilumab vs Janus kinase inhibitors in late- and younger-onset rheumatoid arthritisYuji Nozaki, Kazuya Kishimoto, Tetsu Itami, et al.
Arthritis Research & Therapy|January 4, 2026
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritisYuji Nozaki, Kazuya Kishimoto, Tetsu Itami, et al.
Molecular Cancer Therapeutics|December 2, 2016
A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML CellsYoshinori Ishikawa, Kanae Gamo, Masato Yabuki, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Surgical Case Reports|April 13, 2026
Ileocecal CD5-Positive Diffuse Large B-Cell Lymphoma Presenting with Acute Obstructive Symptoms: A Case ReportJumpei Kashiwagi, Yutaka Hanaoka, Hana Yoshimitsu, et al.
The Laryngoscope|April 13, 2019
Three-dimensional assessment of the pharyngeal airway in Japanese preschoolers with orofacial cleftsMasahiro Takahashi, Tetsutaro Yamaguchi, Myoung K Lee, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
A Chemical Strategy toward Novel Brain-Penetrant EZH2 InhibitorsRui Liang, Daisuke Tomita, Yusuke Sasaki, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2019
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cellsEdouard Mullarky, Jiayi Xu, Anita D Robin, et al.
Journal of Human Genetics|June 7, 2018
Association between the FGFR1 rs13317 single nucleotide polymorphism and orbitale-nasion depth based on cephalometric imagesMohamed Adel, Tetsutaro Yamaguchi, Daisuke Tomita, et al.
Plos One|January 28, 2017
Contribution of FGFR1 Variants to Craniofacial Variations in East AsiansMohamed Adel, Tetsutaro Yamaguchi, Daisuke Tomita, et al.
Rheumatology (Oxford, England)|October 29, 2025
Clinical Efficacy of JAK Inhibitors for Rheumatoid Arthritis Patients with Poor-Prognosis Factors: The ANSWER Cohort StudyYuji Nozaki, Koichi Murata, Akira Onishi, et al.
Rheumatology (Oxford, England)|June 9, 2026
Comparative effectiveness and safety of sarilumab vs Janus kinase inhibitors in late- and younger-onset rheumatoid arthritisYuji Nozaki, Kazuya Kishimoto, Tetsu Itami, et al.
Arthritis Research & Therapy|January 4, 2026
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritisYuji Nozaki, Kazuya Kishimoto, Tetsu Itami, et al.
Molecular Cancer Therapeutics|December 2, 2016
A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML CellsYoshinori Ishikawa, Kanae Gamo, Masato Yabuki, et al.
Pageof 6